[Metabolomics and molecular targeted therapy of cancer].

Metabolomics is defined as the quantitative measurement of the dynamic multiparametric metabolites. Recent technological advances in the quantification of cellular metabolites, such as capillary electrophoresis (CE) -TOFMS, have prompted the comprehensive analysis of the global metabolism. Now, metabolomics has been used in the identification of new biomarker for toxicology and disease diagnosis, and the elucidation of fermentation processes. Moreover, it is considered that metabolomics would be a powerful tool for the target identification of small molecular bioactive compounds. Here we introduce our recent study that metabolomics was applied to identify the molecular target of glucopiericidin A, which was isolated through a screening of natural products for an inhibitor of cellular filopodia protrusion in carcinoma cells.
AuthorsEtsu Tashiro, Masaya Imoto
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 73 Issue 8 Pg. 1268-72 (Aug 2015) ISSN: 0047-1852 [Print] Japan
PMID26281677 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Aminoglycosides
  • glucopiericidin A
  • Aminoglycosides (isolation & purification, pharmacology, therapeutic use)
  • Glycolysis
  • Humans
  • Metabolomics (methods, trends)
  • Mitochondria (metabolism)
  • Molecular Targeted Therapy
  • Neoplasms (metabolism, pathology, therapy)
  • Pseudopodia (drug effects, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: